Clinical Trial Update: A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions [Phase 1, Phase 2]

View source ↗

Summary

A clinical study evaluating alanyl-glutamine to reduce post-surgical pelvic adhesions after myomectomy has completed Phase 1 and Phase 2 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelvic Adhesions

Drugs mentioned

• Alanyl-glutamine (alanyl-glutamine)

Snippet

Sponsor: Temple Therapeutics BV | Conditions: Pelvic Adhesions | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-05-07